GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity
This cohort study examines the associations between glucagon-like peptide-1 receptor agonist (GLP-1 RA) initiation and obesity-related cancer incidence across active comparators and baseline type 2 diabetes severity.
Authors
- Sarah Elizabeth Messiah (ORCID: https://orcid.org/0000-0001-6685-2175)
- Jing Chen (ORCID: https://orcid.org/0000-0002-9035-9126)
- Jesús Gibran Hernández‐Pérez (ORCID: https://orcid.org/0000-0002-7637-4127)
- Jaime P. Almandoz (ORCID: https://orcid.org/0000-0002-0462-0843)
- David S. López (ORCID: https://orcid.org/0000-0002-2321-0372)
- Luisa Torres‐Sánchez (ORCID: https://orcid.org/0000-0002-2902-9881)
- Lindsay Grey Cowell (ORCID: https://orcid.org/0000-0003-1617-8244)
- Omer Abdelgadir (ORCID: https://orcid.org/0009-0002-6104-0156)
Institutions
- Instituto Nacional de Salud Pública (MX)
- Harold C. Simmons Comprehensive Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-11-03
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.41869
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00